Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

All-female gynecologic oncology team treating women at Hackensack University Medical Center

When Linda Muller was diagnosed with serous cell endometrial cancer in 2016, she and her husband George turned to the all-female gynecologic oncology team at John Theurer Cancer Center at Hackensack University Medical Center for her care -; a decision that the couple credits with Linda's complete recovery and continued good health seven years later.

16 Mar 2023

Quiescent ovarian cancer cells secrete a protein to induce chemotherapy resistance in neighboring cells

Certain chemotherapy-resistant ovarian cancer cells protect neighboring cancer cells by sending signals that induce resistance, according to a new study from University of Pittsburgh and UPMC researchers that may help explain why ovarian cancer patients respond poorly to chemotherapy or relapse after treatment.

3 Mar 2023

Women with a BRCA1 or BRCA2 pathogenic variant have high risk of cancer after age 50

Although genetic mutations in BRCA1 or BRCA2 are associated with a younger onset of breast and ovarian cancer, women with these genetic mutations continue to face a high risk of cancer incidence after age 50, even if they have not been previously diagnosed with cancer.

24 Feb 2023

First fully human ovarian organoids provide insights about female reproductive health and disease

Despite the fact that we all start out as an egg cell in one of our mother's ovaries, these human reproductive organs are surprisingly under-studied.

21 Feb 2023

New type of immunotherapy effective in mice with ovarian cancer

CAR T-cell therapy, a certain kind of cancer treatment in which the immune system's T cells are programmed to attack tumor cells, is effective in mice with ovarian cancer, according to a study published in The Journal for ImmunoTherapy of Cancer.

6 Feb 2023

What is the effectiveness of different exercise modalities in reducing cancer-related fatigue in cancer patients undergoing chemotherapy?

Researchers examined the effect of exercise modalities on cancer-related fatigue.

6 Feb 2023

Higher consumption of ultra-processed foods associated with greater risk of developing cancer

Higher consumption of ultra-processed foods may be linked to an increased risk of developing and dying from cancer, an Imperial College London-led observational study suggests.

31 Jan 2023

Loyalty card data on over-the-counter drug purchases could help spot ovarian cancer cases earlier

Loyalty card data on over-the-counter medicine purchases could help spot ovarian cancer cases earlier according to a pioneering study funded by Cancer Research UK.

26 Jan 2023

Lifetime ovulatory years positively associated with epithelial ovarian cancer

Francesmary Modugno, Ph.D., professor of obstetrics, gynecology and reproductive sciences at Magee-Womens Research Institute and UPMC Hillman Cancer Center

25 Jan 2023

Boosting nutritional knowledge with the help of a dietitian specializing in cancer

In a brightly lit kitchen one recent afternoon, cancer survivors Patricia Rhodes and Evette Knight were part of a group gathered around a convection burner and a sauté pan filled with mushrooms.

20 Jan 2023

Early tastings allow infants to eat more food and stop breastfeeding

The earlier infants begin to taste small samples of solid food, the earlier they eat more food and stop breastfeeding.

18 Jan 2023

Cancer mortality in the U.S. has declined 33% since the 90s

The American Cancer Society has recently published the statistics of cancer incidence and mortality for 2023 in CA: A Cancer Journal for Clinicians.

17 Jan 2023

New genetic test could guide the treatment of ovarian cancer

Researchers have developed an optimized genetic test for ovarian cancer, which helps accurately target an effective but expensive medication.

11 Jan 2023

Using machine learning models to guide the design of long-acting injectable drug formulations

Scientists at the University of Toronto have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations.

10 Jan 2023

Novel T cell receptor therapy shows early promise for treating solid tumors

Afamitresgene autoleucel (afami-cel; formerly ADP-A2M4), an adoptive T cell receptor (TCR) therapy targeting the MAGE-A4 cancer antigen, achieved clinically significant results for patients with multiple solid tumor types in a Phase I clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

9 Jan 2023

Clinically relevant biomarker strategies in drug development

In this interview, NewsMedical speaks with Dr. Justin Devine and Dr. Nicholas Woudberg about biomarkers, their importance for drug development as well as the potential they have when it comes to machine learning.

From Synexa Life Sciences BV 9 Jan 2023

High affinity antibodies isolated to safely target Claudin 6-positive tumors

Integral Molecular, the industry leader in antibody discovery for membrane proteins, has published the targeting mechanism enabling best-in-class specificity of its Claudin 6 (CLDN6) antibody CTIM-76 being developed for cancer therapy with Context Therapeutics.

6 Jan 2023

New imaging agent lights the way for surgeons during lung cancer surgery

Surgery, especially surgery to remove cancerous tumors, relies on a range of tools and techniques as well as on the skill of the surgeon.

19 Dec 2022

FDA approves targeted imaging agent for use in lung cancer surgery

The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery.

18 Dec 2022

Genetic testing program could help to close the gap for some patients with prostate cancer

Some patients with prostate cancer have genetic mutations that may impact their treatment. A comprehensive, on-site genetic testing program, pioneered by urologists, could help to close the gap for this underutilized resource, reports a study in Urology Practice®, an Official Journal of the American Urological Association (AUA).

15 Dec 2022

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

All-female gynecologic oncology team treating women at Hackensack University Medical Center

Quiescent ovarian cancer cells secrete a protein to induce chemotherapy resistance in neighboring cells

Women with a BRCA1 or BRCA2 pathogenic variant have high risk of cancer after age 50

First fully human ovarian organoids provide insights about female reproductive health and disease

New type of immunotherapy effective in mice with ovarian cancer

What is the effectiveness of different exercise modalities in reducing cancer-related fatigue in cancer patients undergoing chemotherapy?

Higher consumption of ultra-processed foods associated with greater risk of developing cancer

Loyalty card data on over-the-counter drug purchases could help spot ovarian cancer cases earlier

Lifetime ovulatory years positively associated with epithelial ovarian cancer

Boosting nutritional knowledge with the help of a dietitian specializing in cancer

Early tastings allow infants to eat more food and stop breastfeeding

Cancer mortality in the U.S. has declined 33% since the 90s

New genetic test could guide the treatment of ovarian cancer

Using machine learning models to guide the design of long-acting injectable drug formulations

Novel T cell receptor therapy shows early promise for treating solid tumors

Clinically relevant biomarker strategies in drug development

High affinity antibodies isolated to safely target Claudin 6-positive tumors

New imaging agent lights the way for surgeons during lung cancer surgery

FDA approves targeted imaging agent for use in lung cancer surgery

Genetic testing program could help to close the gap for some patients with prostate cancer

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in